-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Rigel Pharmaceuticals, Raises Price Target to $86

Benzinga·11/09/2026 18:21:25
Listen to the news
Citigroup analyst Yigal Nochomovitz maintains Rigel Pharmaceuticals (NASDAQ:RIGL) with a Buy and raises the price target from $83 to $86.